Results 71 to 80 of about 25,803 (213)
Clozapine responsive catatonia: A series of five cases
The main objective of presenting the case series is that despite dramatic symptomatic response by intra venous lorazepam or electro convulsive therapy irrespective of primary diagnosis in catatonia cases some cases remain difficult to treat by ...
Somsubhra Chattopadhyay +3 more
doaj +1 more source
Lorazepam V Diazepam in Status Epilepticus
A prospective, open, odd and even dates trial of lorazepam compared to diazepam for the treatment of acute convulsions and status epilepticus in 102 children is reported from the Royal Liverpool Children’s NHS Trust, UK.
J Gordon Millichap
doaj +1 more source
Olanzapine was more effective than lorazepam at 2 hours but not at 24 hours in bipolar mania with acute agitation [PDF]
R. Kerwin
openalex +1 more source
Machine learning methods for predicting adverse drug events: A systematic review
Abstract Predicting adverse drug events (ADEs) in outpatient settings is crucial for improving medication safety, identifying high‐risk patients and reducing health‐care costs. While traditional methods struggle with the complexity of health‐care data, machine learning (ML) models offer improved prediction capabilities; however, their effectiveness in ...
Niaz Chalabianloo +8 more
wiley +1 more source
Abstract BNC210 is an investigational small molecule selective negative allosteric modulator of the alpha‐7 nicotinic acetylcholine receptor (α7 nAChR). It is an anxiolytic compound with a novel mechanism of action. In a series of Phase 1 clinical trials in healthy volunteers, psychometric test batteries showed that BNC210 did not cause attention ...
Paul Rolan +7 more
wiley +1 more source
Quantitative Analysis of Lorazepam in Pharmaceutical Formulation Through FTIR Spectroscopy
A Fourier transform infrared (FTIR) spectrophotometric method was development for the rapid, direct measurement of lorazepam in different pharmaceutical products.
Elaheh Konoz +3 more
doaj +1 more source
Benzodiazepines (BZDs) remain the mainstay in the management of withdrawal arising out of BZD use disorders. The choice of detoxifying agent is determined by the duration of action and also by the metabolic properties of the drug.
Vrinda Saxena, Robin Victor, Arghya Pal
doaj +1 more source
Duplicate Prescription Patterns in Patients With Substance Use Disorders
ABSTRACT This study sought to investigate the frequency and characteristics of duplicate prescriptions (DPs) in psychiatric inpatients with substance use disorders using a DP classification that differentiates between appropriate DPs (ADPs) and potentially inappropriate DPs (PIDPs). The study was conducted as a monocentric retrospective cross‐sectional
Johannes Heck +8 more
wiley +1 more source
Missed Diagnosis of Major Depressive Disorder with Catatonia Features
Catatonia is often a presentation of extreme anxiety and depression. Missing the diagnosis of catatonia would lead to improper treatment, which could be life-threatening.
Harry Jhawer +2 more
doaj +1 more source
Supplementary Figure S5 from Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer [PDF]
Abigail C. Cornwell +16 more
openalex +1 more source

